Steve Schonfeld’s Arbutus Biopharma ABUS Stock Holding History
Bought
Maintained
Sold
Other funds holding ABUS
Steve Schonfeld's ABUS Position: Q3 2026 in Review
Steve Schonfeld opened a new position in Arbutus Biopharma (ABUS) in Q3 2026: 90,008 shares worth $430K. The stake represents ﹤0.01% of the portfolio and ranks #2038 among its holdings. This is a return to the name: Steve Schonfeld previously reported a position in ABUS as recently as Q3 2022.
Steve Schonfeld first reported a position in ABUS in Q3 2017 and has held it in 6 quarters since. The position peaked at $775K in Q3 2017. 216 funds tracked by Wall St. Rank hold ABUS as of Q3 2026.
- Steve Schonfeld held 90,008 shares of Arbutus Biopharma worth $430K as of Q3 2026.
- Arbutus Biopharma was a new Steve Schonfeld position in Q3 2026.
- Arbutus Biopharma made up ﹤0.01% of Steve Schonfeld's portfolio in Q3 2026, its #2038 holding.
- Steve Schonfeld first reported a position in Arbutus Biopharma in Q3 2017 and has held it in 6 quarters since.
- Steve Schonfeld's Arbutus Biopharma position peaked at $775K in Q3 2017.
- 216 funds tracked by Wall St. Rank held Arbutus Biopharma as of Q3 2026.
Based on Schonfeld Strategic Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.